Charlotte Allerton

Senior Vice President, Head of Medicine Design at Pfizer

Charlotte Allerton
Credit: Courtesy of Charlotte Allerton

Charlotte Allerton is Senior Vice President and Head of Medicine Design in Pfizer. Medicine Design includes the scientific disciplines of Medicinal Chemistry, Pharmacokinetics, Dynamics and Metabolism (PDM), and Hit Discovery and Lead Optimization capabilities, enabling a deep focus on the design and delivery of small molecule medicines across Pfizer’s core disease areas.

Charlotte joined Medicinal Chemistry in Pfizer, Sandwich in 1993, and spent 14 years working across a range of therapeutic areas, including a secondment to Japan to partner on pain research. In 2007, Charlotte joined PDM as the Genitourinary Therapeutic Area Lead, progressing to take the role of Sandwich PDM site lead in 2009. She moved to Cambridge UK in 2011 to lead Pre-Clinical Sciences for the Neusentis Pain Research Unit, overseeing DMPK, drug safety and pharmaceutical sciences capabilities. In 2012, Charlotte took on leadership of the small molecule PDM line and re-located with her family to the U.S.A. In 2016 she took on leadership of Medicine Design.

Charlotte obtained her BSc from the University of Nottingham in 1993 and MPhil in organic chemistry from the University of Cambridge in 1997.